PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: In vitro evaluation in human prostate cancer cells

International Journal of Pharmaceutics

Volumn 317, Issue 1, 2006, Pages 10-13

  Moffatt, Stanley ^a   Cristiano, Richard J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

J591mAb; Phenyl(di)boronic acid (PDBA) salicyl hydroxamic acid (SHA); PLGA PEG PLGA; Polyethyleneimine (PEI); Prostate specific membrane antigen (PSMA); Targeted gene delivery

Indexed keywords

BENZENEBORONIC ACID; BETA GALACTOSIDASE; COPOLYMER; HYDROXAMIC ACID DERIVATIVE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY J591; PLASMID DNA; POLOXAMER; POLYETHYLENE DERIVATIVE; POLYGLACTIN POLYETHYLENE GLYCOL POLYGLACTIN COPOLYMER; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL NUCLEUS; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DERIVATIZATION; DRUG FORMULATION; ENCAPSULATION; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; MALE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; DNA; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; MALE; PLASMIDS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; POLYMERS; PROSTATIC NEOPLASMS; TRANSFECTION;

EID: 33744983051     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.04.011     Document Type: Article

References (19)

1. Brown M.D., Schatzlein A.G., et al. Gene delivery with synthetic (non viral) carriers. Int. J. Pharm. 229 (2001) 1-21
2. Cristiano R.J., Smith L.C., et al. Hepatic gene delivery: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. 90 (1993) 2122-2126
3. Deng X.M., Xiong C.D., et al. Synthesis and characterization of block copolymers from d,l-lactide and poly(ethylene glycol) with stannous chloride. J. Polym. Sci. Polym. Lett. 13 (1990) 411-416
4. Feng S.S., Mu L., et al. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr. Med. Chem. 11 (2004) 413-424
5. Hedley M.L., Curley J., et al. Microspheres containing plasmid-encoded antigens elicit cytotoxic T cell responses. Nat. Med. 4 (1998) 365-368
6. Horoszewicz J.S., Kawinski E., et al. Monoclonal antibodies to a new antigenic marker in epithelial prostate cells and serum of prostatic cancer patients. Anticancer Res. 7 (1987) 927-936
7. Jenkins R.G., Herrick S.E., et al. An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Ther. 7 (2001) 393-400
8. LaPorte R.J. In: Laporte R.J. (Ed). Hydrophilic Polymer Coatings for Medical Devices: Structure/Properties, Development, Manufacture, and Applications (1997), Technomic Publishing Co., Lancaster, PA
9. Li X., Deng X., et al. In vitro degradation and release profiles of poly dl-lactide-poly(ethylene glycol) microspheres with entrapped proteins. J. Appl. Polym. Sci. 1 (2000) 140-148
10. Liu H., Rajasekaran A.K., et al. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res. 58 (1998) 4055-4060
11. Luo D. A new solution for improving gene delivery. Trends Biotech. 22 (2004) 101-103
12. Men Y., Tamber H., et al. Induction of a cytotoxic T lymphocyte response by immunization with a malaria-specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine 15 (1997) 1405-1412
13. Moffatt S., Wiehle S., et al. Tumor-specific gene delivery mediated by a novel peptide-polyethlenimine-DNA polyplex targeting aminopeptidase N (CD13). Hum. Gene Ther. 16 (2005) 57-67
14. Moffatt S., Papasakelariou C., et al. Successful in vivo tumor targeting of prostate specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate. Gene Ther. 13 (2006) 761-772
15. Mu L., and Feng S.S. Fabrication, characterization and in vitro release of paclitaxel (Taxil) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control. Release 3 (2001) 239-254
16. O'keefe D.S., Uchida A., et al. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer. Prostate 45 (2000) 149-157
17. Stolowitz M.L., Ahlem C., et al. Phenylboronic acid-salicylhydroxamic acid bioconjugates. 1. A novel boronic acid complex for protein immobilization. Bioconjug. Chem. 12 (2001) 229-239
18. Verma I.M., and Somia N. Gene therapy-promises, problems and prospects. Nature 389 (1997) 239-242
19. Ziady A., Ferkol T., et al. Chain length of the polymer portion of receptor-targeted DNA complexes modulates gene transfer both in vitro and in vivo. J. Biol. Chem. 274 (1999) 4908-4916